Evolving Practices for Myelodysplastic Syndromes (MDS): Highlights from ASH 2024 and Beyond - Episode 7
A Deep Dive Into Treatment Approaches for Patients With MDS by Risk Status
Panelists discuss how treatment strategies for myelodysplastic syndromes (MDS) are fundamentally guided by risk stratification, with lower-risk patients typically receiving supportive care and less intensive treatments focused on quality of life and symptom management while intermediate- to high-risk patients require more aggressive approaches, including hypomethylating agents and consideration for stem cell transplantation, with emerging data supporting novel combinations and targeted therapies across the risk spectrum.
Video Player is loading.
Video content above is prompted by the following:
Related Content:
